Jupiter Neurosciences, Inc. With a focus on making a significant impact for patients and society, their mission is to develop safe and oral medication for Alzheimer's disease and rare diseases. The company has pioneered Micellar Technology, which allows for the development of resveratrol products that reach therapeutic levels without causing any gastrointestinal side effects.

This breakthrough enables treatment possibilities in various indications. Jupiter Neurosciences' flagship product, JOTROL™, stands out as the first of its kind. It possesses anti-inflammatory and oxidative-stress-reducing properties, among other mechanisms of action, making it potentially effective for multiple diseases.

The patented micellar form of the JOTROL™ delivery platform allows resveratrol to be easily consumed in an oral softgel. Notably, this product can effectively cross the blood-brain barrier, enabling treatment of the central nervous system. Safety is a top priority, and Jupiter Neurosciences ensures that their products are safe and effective for treating several diseases.

With a long-term focus on Alzheimer's disease and rare diseases, they invite the best partners to join their mission of developing groundbreaking treatments